About Metabolomic Diagnostics
Metabolomic Diagnostics is a company based in Cork (Ireland) founded in 2011. Metabolomic Diagnostics has raised $3.89 million across 7 funding rounds from investors including Enterprise Ireland, European Union and EIC Fund. Metabolomic Diagnostics offers products and services including Biomarker Diagnostic Pipeline and Mass Spectrometry Solutions. Metabolomic Diagnostics operates in a competitive market with competitors including Celmatix, adyn, LIA Diagnostics, Confer Health and Milu Labs, among others.
- Total Equity Funding$3.89M (USD)
in 7 rounds
- Latest Funding Round$60.68K (USD), Grant
Jan 2021
- InvestorsEnterprise Ireland
& 5 more
Products & Services of Metabolomic Diagnostics
Metabolomic Diagnostics offers a comprehensive portfolio of products and services, including Biomarker Diagnostic Pipeline and Mass Spectrometry Solutions.
System for identifying and translating biomarkers into clinical assays
Tools for multiplexing biomarkers in disease diagnostics
Apps and channels of Metabolomic Diagnostics
its YouTube channel Metabolomic Diagnostics has 15 subscribers and 6 videos.
Videos from Metabolomic Diagnostics
The most watched videos on Metabolomic Diagnostics's YouTube channel, Metabolomic Diagnostics (15 subscribers). Click a video to play it here.
More on Metabolomic Diagnostics.
Funding Insights of Metabolomic Diagnostics
Metabolomic Diagnostics has successfully raised a total of $3.89M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $60.68 thousand completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.89M
- Total Rounds 7
- Last Round Grant — $60,681
- First Round $1.03M
(Jan 2014)
- Investors Count 6
All 7 funding rounds of Metabolomic Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | $60,681 | Grant | – | – | |
| Nov 2018 | $2.16M | Grant | – | – | |
| Jun 2018 | $205,200 | Grant | – | – | |
| May 2018 | $2.39M | Grant | – | – | |
| Jun 2016 | $2M | Seed | – | – | |
| Feb 2015 | $858,690 | Seed | – | – | |
| Jan 2014 | $1.03M | Seed | – | – |
6 investors in total: 6 institutional.
Investors in Metabolomic Diagnostics
Metabolomic Diagnostics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Enterprise Ireland, European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | – | eicfund.eu | Brussels, Belgium | |
Venture capital and accelerator services are provided across multiple sectors. | – | sosv.com | Cork, Ireland | |
- | – | aibseedcapitalfund.ie | - | |
Venture capital funding is provided for early-stage Irish companies. | – | enterpriseequity.ie | Dun Laoghaire, Ireland | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Support is provided to Irish manufacturing and service sector businesses. | 1998 | enterprise-ireland.com | Dublin, Ireland |
Investor details for Metabolomic Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Metabolomic Diagnostics
7 people are tracked at Metabolomic Diagnostics (2 in leadership, 3 in board & advisors, 2 in team).
| Name | Role | Group |
|---|---|---|
Ana Panigassi | Head of Clinical Affairs & In-House Obstetrician | Leadership |
Robin Tuytten | CEO | Leadership |
Bill Liao | Advisor | Board & advisors |
Declan O’Mahoney | Advisor | Board & advisors |
Jim Walsh | Advisor | Board & advisors |
Elizabeth Berkelaar | Office Manager& Executive Assistant | Team |
Louise Kenny | Principal Investigator | Team |
Complete people profiles for Metabolomic Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Metabolomic Diagnostics
3 dated milestones of Metabolomic Diagnostics across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Metabolomic Diagnostics is founded.
- Funding First funding round of $1.0M.
- Funding Latest funding round, Grant, of $61K.
Competitors of Metabolomic Diagnostics
Metabolomic Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celmatix, adyn, LIA Diagnostics, Confer Health and Milu Labs, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| celmatix.com | 2009 | New York, United States | $24.89M | 27 | Fertility decisions are optimized using data analytics and genomics. | |
| adyn.com | 2019 | Seattle, United States | $2.65M | – | Provider of DNA and hormone analysis based birth control optimization kits | |
| liadiagnostics.com | 2015 | Philadelphia, United States | $4.22M | – | Disposable paper pregnancy test kits | |
| confer.health | 2015 | Boston, United States | $9.5M | – | Clinical-grade diagnostic tests for home use are developed. | |
| milulabs.com | 2018 | New York, United States | – | – | Exosome-based diagnostic products for health screening are offered. | |
| jabrehoo.com | 2011 | Beijing, China | $14.35M | – | Next-generation sequencing services for assisted reproduction are integrated. | |
| informbio.com | 2014 | Cork, Ireland | – | – | Personalized molecular diagnostics using metabolomics. |
Detailed competitors of Metabolomic Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Metabolomic Diagnostics
Complete news archive for Metabolomic Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Metabolomic Diagnostics
10 companies that operate in the same segment as Metabolomic Diagnostics (Women's Health & Fertility), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Silicone-filled breast and body shaping implants are designed and manufactured. | 2010 | Alajuela, Alajuela, Costa Rica | USD 121 M | USD 211.08 M | 1,020 | |
Immunotherapeutics for cancer and other diseases are developed. | 2008 | Mainz, Rhineland-palatinate, Germany | USD 805.99 M | USD 3.24 B | 6,770 | |
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 124.07 M | USD 19.59 M | – | |
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | – | 47 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Platform for breast ultrasound imaging | 2010 | Plymouth, Massachusetts, United States | USD 136.54 M | – | – | |
Silicone breast implants are developed for reconstruction and aesthetic surgery. | 2007 | Dublin, Ireland | USD 232.81 M | – | – | |
A minimally invasive ablation system for uterine fibroids is developed. | 2005 | Redwood City, California, United States | USD 282.54 M | – | 92 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Metabolomic Diagnostics
Metabolomic Diagnostics was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Metabolomic Diagnostics is headquartered in Cork, Ireland.
Metabolomic Diagnostics is a funded company, having raised a total of $3.89M across 7 funding rounds to date. The company's 1st funding round was a Seed of $1.03M, raised on Jan 2014.
Metabolomic Diagnostics was founded in 2011 in Cork, Ireland, where diagnostics and prognostics for maternal health are developed through metabolic profiling. Focus is placed on an early pregnancy test that identifies pre-eclampsia risk by analyzing panels of implicated metabolites. Operations include a subsidiary, Inform Bioscience, within the healthcare diagnostics sector.
Metabolomic Diagnostics's top competitors include Celmatix, LIA Diagnostics and adyn.
Metabolomic Diagnostics offers Biomarker Diagnostic Pipeline and Mass Spectrometry Solutions.
Metabolomic Diagnostics has 6 investors. Key investors include Enterprise Ireland, European Union, EIC Fund, SOSV, and AIB Seed Capital Fund.